Patient Access Insights

Health Economics for Non-Health Economists

In this webinar, our Health Economics team provide an introduction to this topic, to early Health Economic models and explain the advantages of modelling.
Request this webinar

Health Economics for Non-Health Economists

Originally broadcast: Tuesday, 5th May 2020

Duration: 60 minutes. Available to watch on demand

Learning objectives:

  •  Consider why we need economic evaluations

  •  Explain what a QALY is

  •  Describe how to derive utility

  •  Recognise the advantages of modelling

  •  Understand the importance of developing early health economic models

  •  Identify types of early health economic models

  •  Understand types of analyses in early health economic models

  •  Discuss lessons learnt from HTA bodies’ critique of models using case studies

  • The Pharma and MedTech job functions that will benefit most include:

  •  Heads of Market Access

  •  Country Managers

  •  Commercial Directors

  •  Marketing Directors

  •  Managing Directors

  •  Chief Executives

  •  Medical Directors

  •  Policy Officers and Executives

  •  Policy Advisors

Christian%201x
Christian Hill

Chief Executive Officer


Peter

Peter Rouse

Senior Consultant
Health Economics and Outcomes Research

Nermina

Nermina Ferizović

Consultant
Health Economics and Outcomes Research and Real-world Evidence

If you are unable to join the live Webinar, please still register and we will forward the slide decks afterwards.

Terms and ConditionsComplaints ProcedurePrivacy PolicyCookie Policy

Copyright © 2020. MAP BioPharma Limited. All rights reserved.

MAP BioPharma Limited
Upper Pendrill Court, Ermine Street North
Papworth Everard, Cambridge
Cambridgeshire, CB23 3UY
United Kingdom

+44 (0) 1480 832360

 enquiries@mapbiopharma.com

MAP BioPharma Limited is a registered company in England and Wales. Company Registration Number 08209281

VAT Group Registration Number GB 292 8576 52